Global Cord Blood Corporation
Symbol: CO
NYSE
2.9876
USDMarket price today
5.2326
P/E Ratio
-0.0019
PEG Ratio
400.08M
MRK Cap
- 0.00%
DIV Yield
Global Cord Blood Corporation (CO) Stock Price & Analysis
Shares Outstanding
0M
Gross Profit Margin
0.85%
Operating Profit Margin
0.49%
Net Profit Margin
0.40%
Return on Assets
0.06%
Return on Equity
0.11%
Return on Capital Employed
0.08%
Company general description and statistics
General Outlook
Return on Investments
Stock Prices
Liquidity Ratios
Analyzing CO liquidity ratios reveals its financial health of the firm. The current ratio of 1072.60% gauges short-term asset coverage for liabilities. The quick ratio (1055.17%) assesses immediate liquidity, while the cash ratio (1030.22%) indicates cash reserves.
cards.indicator | cards.value |
Current Ratio | 1072.60% |
Quick Ratio | 1055.17% |
Cash Ratio | 1030.22% |
Profitability Ratios
CO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 50.50% underscores its earnings before tax deductions. The effective tax rate stands at 18.85%, revealing its tax efficiency. The net income per EBT, 79.81%, and the EBT per EBIT, 103.12%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 48.97%, we grasp its operational profitability.
cards.indicator | cards.value |
Pretax Profit Margin | 50.50% |
Effective Tax Rate | 18.85% |
Net Income per EBT | 79.81% |
EBT per EBIT | 103.12% |
EBIT per Revenue | 48.97% |
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 10.73, it details the span from stock purchase to revenue. The 11 days it takes to settle debts showcases its creditor relations. Meanwhile, a 10 cash conversion cycle and 770.76% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator | cards.value |
Days of Sales Outstanding | 1055 |
Days of Inventory Outstanding | 91 |
Operating Cycle | 138.71 |
Days of Payables Outstanding | 17 |
Cash Conversion Cycle | 122 |
Receivables Turnover | 7.71 |
Payables Turnover | 22.01 |
Inventory Turnover | 4.00 |
Fixed Asset Turnover | 2.61 |
Asset Turnover | 0.15 |
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 5.05, and free cash flow per share, 4.89, depict cash generation on a per-share basis. The cash per share value, 54.80, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.49, offers insight into cash flow relative to sales.
cards.indicator | cards.value |
Operating Cash Flow per Share | 5.05 |
Free Cash Flow per Share | 4.89 |
Cash per Share | 54.80 |
Operating Cash Flow Sales Ratio | 0.49 |
Free Cash Flow to Operating Cash Flow Ratio | 0.97 |
Cash Flow Coverage Ratio | 4174.20 |
Short Term Coverage Ratio | 4174.20 |
Capital Expenditure Coverage Ratio | 31.01 |
Dividend Paid and Capex Coverage Ratio | 31.01 |
Debt and Leverage Ratios
An interest coverage of -15.79 indicates its ability to manage interest expenses.
cards.indicator | cards.value |
Interest Coverage | -15.79 |
Cash Flow to Debt Ratio | 4174.20 |
Company Equity Multiplier | 1.75 |
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 10.23, provides a glimpse into top-line earnings distributed across each share. Net income per share, 4.12, reflects the portion of profit attributed to each share. The book value per share, 40.14, represents the net asset value distributed per share, while the tangible book value per share, 39.50, excludes intangible assets.
cards.indicator | cards.value |
Revenue Per Share | 10.23 |
Net Income Per Share | 4.12 |
Book Value Per Share | 40.14 |
Tangible Book Value Per Share | 39.50 |
Shareholders Equity Per Share | 40.14 |
Interest Debt Per Share | -0.32 |
Capex Per Share | -0.16 |
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -3,683,367,448.453, captures the company's total value, considering both debt and equity. Income quality, 1.20, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.15, gauges operational efficiency, while the research and development to revenue, 1.79%, highlights investment in innovation. The ratio of intangibles to total assets, 0.98%, indicates the value of non-physical assets, and capex to operating cash flow, -3.23%, measures reinvestment capability.
cards.indicator | cards.value |
Enterprise Value | -3,683,367,448.453 |
Income Quality | 1.20 |
Sales General and Administrative to Revenue | 0.15 |
Research and Development to Revenue | 1.79% |
Intangibles to Total Assets | 0.98% |
Capex to Operating Cash Flow | -3.23% |
Capex to Revenue | -1.59% |
Capex to Depreciation | -41.29% |
Graham Number | 61.02 |
Return on Tangible Assets | 5.93% |
Graham Net Net | 25.96 |
Working Capital | 6,288,445,000 |
Tangible Asset Value | 4,801,391,000 |
Net Current Asset Value | 3,285,450,000 |
Average Receivables | 145,800,000 |
Average Payables | 8,904,500 |
Average Inventory | 45,068,000 |
Days Sales Outstanding | 47 |
Days Payables Outstanding | 17 |
Days of Inventory On Hand | 91 |
ROIC | 10.13% |
ROE | 0.10% |
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.54, and the price to book ratio, 0.54, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.32, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 4.86, and price to operating cash flows, 4.27, gauge market valuation against cash flow metrics.
cards.indicator | cards.value |
Price Book Value Ratio | 0.54 |
Price to Book Ratio | 0.54 |
Price to Sales Ratio | 2.32 |
Price Cash Flow Ratio | 4.27 |
Enterprise Value Multiple | 15.19 |
Price Fair Value | 0.54 |
Price to Operating Cash Flow Ratio | 4.27 |
Price to Free Cash Flows Ratio | 4.86 |
Price to Tangible Book Ratio | 0.61 |
Enterprise Value to Sales | -2.96 |
Enterprise Value Over EBITDA | -5.86 |
EV to Operating Cash Flow | -6.00 |
Earnings Yield | 16.83% |
Free Cash Flow Yield | 19.94% |
Frequently Asked Question
How many company shares are outstanding in 2024?
There are stock number shares outstanding of Global Cord Blood Corporation (CO) on the NYSE in 2024.
What is P/E ratio of enterprise in 2024?
The current P/E ratio of enterprise is 5.233 in 2024.
What is the ticker symbol of Global Cord Blood Corporation stock?
The ticker symbol of Global Cord Blood Corporation stock is CO.
What is company IPO date?
IPO date of Global Cord Blood Corporation is 2007-05-09.
What is company current share price?
Current share price is 2.988 USD.
What is stock market cap today?
The market cap of stock today is 400084454.000.
What is PEG ratio in 2024?
The current -0.002 is -0.002 in 2024.
What is the number of employees in 2024?
In 2024 the company has 1202.